| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/26/2005 | CN1571654A Oral care substance delivery strip |
| 01/26/2005 | CN1569928A Edible nanocore-shell colloid and its preparation method |
| 01/26/2005 | CN1569860A Diol containing phosphatidylcholine and use thereof |
| 01/26/2005 | CN1569233A Method for manufacturing gene medicine for preventing and treating SARS and its medicinal prescription |
| 01/26/2005 | CN1569232A Medicament protecting agent capable of resisting cold, increasing dissolution and resisting oxidation |
| 01/26/2005 | CN1569203A 'Wenweishu' soft capsule and its preparation |
| 01/26/2005 | CN1569148A Medicament for preventing and treating rheumatic arthritis, rheumatoid disease and sciatic neuralgia and its preparation |
| 01/26/2005 | CN1569070A Medicine capable of relieving superficial pathologic factors to dissipate heat and soothing liver to normalize stomach function |
| 01/26/2005 | CN1569043A Coated micro capsule of lactic acid bacteria and its preparation |
| 01/26/2005 | CN1569005A Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 01/26/2005 | CN1568994A Targeted freeze dried nanometer powder injection of hydroxycamptothecine bean phospholipid and its preparation and usage |
| 01/26/2005 | CN1568985A Orally disintegrating tablet of Huperzine A and its preparation |
| 01/26/2005 | CN1568969A Preparing method and usage of vitamin E clathrate |
| 01/26/2005 | CN1568963A Taxusol composition and its preparing process |
| 01/26/2005 | CN1568951A Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 01/26/2005 | CN1568941A Mouth disaggregating tablet and preparation method thereof |
| 01/26/2005 | CN1568940A Preparation method of biont coherent particulates pharmaceutical preparation |
| 01/26/2005 | CN1186014C Multi-particulate pharmaceutical form with programmed and timed releasing and preparation method thereof |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/26/2005 | CN1186012C Continuously releasing ionic conjuncts |
| 01/26/2005 | CN1186009C Pharmaceutical composition for dymenorrhea and premature labor |
| 01/25/2005 | US6846921 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846891 Coating and binding agent for oral or dermal pharmaceutical forms |
| 01/25/2005 | US6846844 (3R)-5-((2-hydroxy-4-methylphenyl)amino)-3-methyl-5-oxo-pentan oic acid, or 3,5-dichloro derivative or salts thereof; deliver active agents to selected biological systems in increased or improved bioavailability |
| 01/25/2005 | US6846841 Anti-angiogenic compositions and methods of use |
| 01/25/2005 | US6846837 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| 01/25/2005 | US6846809 Generating transfection liquids; obtain nutrient broths, incubate with nucleic acids, monitor ionic mobility, store |
| 01/25/2005 | US6846801 Systemic administration of a therapeutic preparation |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/25/2005 | US6846649 Recombinant human mannan-binding lectin |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/25/2005 | US6846495 Respiratory system disorders; dextromethorphan in anhydrous solvents |
| 01/25/2005 | US6846490 Enhance hydrophobicity of a biological surface by applying vernix and a dispersant |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/25/2005 | CA2354695C Compositions and methods for amelioration of human female sexual dysfunction |
| 01/25/2005 | CA2204769C Hemorrhoidal compositions and method of use |
| 01/25/2005 | CA2169159C Pharmaceutical composition containing a drug/.beta.-cyclodextrin complex in combination with an acid-base couple |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/25/2005 | CA2089853C Polyethylene glycol-hirudine conjugates, process for their preparation, and their use in thrombosis therapy |
| 01/20/2005 | WO2005006356A1 Magnetic nanoparticles having improved magnetic properties |
| 01/20/2005 | WO2005005548A1 Conjugate of fine porous particles with polymer molecules and utilization thereof |
| 01/20/2005 | WO2005005484A1 Functional starch powder |
| 01/20/2005 | WO2005005455A2 Specific human antibodies |
| 01/20/2005 | WO2005004925A1 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell |
| 01/20/2005 | WO2005004924A1 Active substance excipient system |
| 01/20/2005 | WO2005004922A1 Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 01/20/2005 | WO2005004920A1 Stable non-dihydrate azithromycin oral suspensions |
| 01/20/2005 | WO2005004918A1 Enhancement of development of oviparous species by in ovo feeding of enteric modulators |
| 01/20/2005 | WO2005004916A2 Modified calcium phosphate excipient |
| 01/20/2005 | WO2005004901A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 01/20/2005 | WO2005004878A2 Multi-use vessels for vitamin d formulations, preferably administeredat high dose and periodically |
| 01/20/2005 | WO2005004856A1 Antifungal composition |
| 01/20/2005 | WO2005004852A1 Pharmaceutical formulations |
| 01/20/2005 | WO2005004848A1 The solid dispersion of tacrolimus |
| 01/20/2005 | WO2005004844A1 Hfc solution formulations containing an anticholinergic |
| 01/20/2005 | WO2005004843A1 Microemulsions and its use for preventing airway diseases |
| 01/20/2005 | WO2005004842A2 Formulations for coated microprojections containing non-volatile counterions |
| 01/20/2005 | WO2005004840A2 Non-gelatin film and method and apparatus for producing same |
| 01/20/2005 | WO2005004838A1 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 01/20/2005 | WO2005004809A2 Multivalent carriers of bi-specific antibodies |
| 01/20/2005 | WO2005004795A2 Compositions and methods for targeted drug delivery |
| 01/20/2005 | WO2005004792A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004100995B1 Targeted delivery of anti-viral compounds through hemoglobin bioconjugation |
| 01/20/2005 | WO2004093845A3 Ligand-coupled initiator polymers and methods of use |
| 01/20/2005 | WO2004089355A3 Compositions for treating microbial and parasitic infections in cattle and other animals |
| 01/20/2005 | WO2004087758A3 Il 13 receptor alpha 2 antibody and methods of use |
| 01/20/2005 | WO2004082576A3 Direct compressible trehalose solids |
| 01/20/2005 | WO2004075922A3 Compounds comprising at least one active substance and at least one carrier which are connected by a binding agent, uses thereof and said binding agents |
| 01/20/2005 | WO2004074345A3 Carbonate esters of polyethylene glycol activated by means of oxalate esters |
| 01/20/2005 | WO2004064761A3 Therapeutically active compounds |
| 01/20/2005 | WO2004064758A3 Improved oral delivery of peptides |
| 01/20/2005 | WO2004050698A3 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 01/20/2005 | WO2004012791A3 Improved injection system |
| 01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 01/20/2005 | US20050015263 Therapy for central nervous system disorders; amyotropic lateral sclerosis; anticancer agents; eating disorders; viricides |
| 01/20/2005 | US20050014903 Thiol selective water soluble polymer derivatives |
| 01/20/2005 | US20050014832 Treatment |
| 01/20/2005 | US20050014825 Preparation and use of solidified oils |
| 01/20/2005 | US20050014823 Sprayable homogeneous solution containing local anesthetic agent, penetration enhancer, anhydrous volatile solvent and water; fast acting, simple, reliable |
| 01/20/2005 | US20050014718 Tumor specific oligosaccharide sequences and use thereof |
| 01/20/2005 | US20050014681 Bioavailability; uniform dispersion, embedding polypeptide and water insoluble carrier |
| 01/20/2005 | US20050014289 Stable compositions for measuring human natriuretic peptides |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014240 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders |
| 01/20/2005 | US20050014207 Monoclonal antibody hPAM4 |
| 01/20/2005 | US20050014167 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 01/20/2005 | US20050013924 Electrostatically depositing active materials as dry powder onto polymer substrate |
| 01/20/2005 | US20050013877 Strontium compound for treatment of sub-dermal soft tissue pain |
| 01/20/2005 | US20050013874 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticles and therapeutic agent for treating zinc deficiency |
| 01/20/2005 | US20050013871 Pharmaceutical composition for the treatment of itch |
| 01/20/2005 | US20050013868 Preparation of submicron sized nanoparticles via dispersion lyophilization |
| 01/20/2005 | US20050013866 Particulate vectors for improving oral absorption of active principles |
| 01/20/2005 | US20050013864 In situ administering; mixture of bone morphogenic protein and ethylene oxide-propylene oxide copolymer |
| 01/20/2005 | US20050013862 Functional powders for oral delivery |
| 01/20/2005 | US20050013861 Agglomerant of microcrystalline cellulose and silica; controlling particle size |
| 01/20/2005 | US20050013852 Rapid release, water permeable self adhesive polymer matrix system; photodynamic therapy and/or diagnosis of skin lesions |
| 01/20/2005 | US20050013847 Delivery systems of homogeneous, thermoreversible alginate films |
| 01/20/2005 | US20050013835 Stable non-dihydrate azithromycin oral suspensions |